Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Leukemia
>>
Biogen
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
42
84
126
168
210
252
294
336
378
420
Rituxan
(rituximab) / Roche
Gazyva
(obinutuzumab) / Roche, Biogen, Nippon Shinyaku
Intron A
(interferon α-2b) / Merck (MSD), Biogen
Zinbryta
(daclizumab) / Biogen, AbbVie